TNDM · Tandem Diabetes Care Inc
United States · RS rating 54 · As of 2026-11-03
| Price | 17.65 USD |
|---|---|
| 1-day change | -5.5% |
| RS rating (overall / 1M / 3M / 12M) | 54 / 76 / 46 / 73 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 37 / 20 / 51 |
| Industry group (rank) | Medical-Products (106) |
| EPS growth Q/Q | +96.8% |
| Sales growth Q/Q | +16.5% |
| Distance from 52-week high | +37.5% |
| Market cap (USD) | $1.4B |